Shavawn K. Ryan, PA-C

Shavawn Ryan practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Shavawn Ryan's NPI, 1467799148, was assigned on January 15, 2013. Shavawn Ryan holds California license PA53367.

Shavawn Ryan's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Shavawn Ryan's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Shavawn Ryan is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Shavawn Ryan to 1 more hospital and 3 medical groups, each named with a free account. Shavawn Ryan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Shavawn Ryan practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Shavawn Ryan's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Shavawn Ryan is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Shavawn Ryan's licenses on file in 2 states: California and Ohio.

Dmand AI lists acute skin infection among the conditions Shavawn Ryan treats.

CMS data shows 60 Medicare services from Shavawn Ryan across 2 procedure codes in 2024, all of them office visits, for 73 Medicare patients. Medicare paid $2,405 for them. Every service was in an office.

CMS counts 73 Medicare patients who saw Shavawn Ryan in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shavawn Ryan's median patient age at 70, with 60% women.

In 2024, Shavawn Ryan wrote 54 Medicare Part D claims for 23 patients. 46% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $21,551 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Shavawn Ryan for performance year 2024, reported as part of a group. Shavawn Ryan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Shavawn Ryan as offering telehealth.

CMS Open Payments shows 10 general payments to Shavawn Ryan from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $199.